Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 21, 2022
- Accession no.
- 0001209191-22-020453
- Filed
- Mar 21, 2022
- Trade date
- Mar 17-21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $3.43M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | Common Stock | PPurchaseAcquired | +10,120 | $18.78 | +$190,053.6 | 538,295 | Indirect | |
| Mar 18, 2022 | Common Stock | PPurchaseAcquired | +5,992 | $19.28 | +$115,525.76 | 544,287 | Indirect | |
| Mar 18, 2022 | Common Stock | PPurchaseAcquired | +76,208 | $20.38 | +$1,553,119.04 | 620,495 | Indirect | |
| Mar 21, 2022 | Common Stock | PPurchaseAcquired | +74,852 | $20.73 | +$1,551,681.96 | 695,347 | Indirect | |
| Mar 21, 2022 | Common Stock | PPurchaseAcquired | +879 | $21.22 | +$18,652.38 | 696,226 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.